From peptide 2° structures to small molecule inhibitors: the Edelris Discovery ENgine (EDEN)

webinar

Wed, 04 Nov 2015, 16:00 CET (Berlin)

Dr. Didier Roche, Edelris France

From peptide 2° structures to small molecule inhibitors: the Edelris Discovery ENgine (EDEN)

Edelris has pioneered for the past decade the design and synthesis of innovative, natural product-like small molecules (Keymical CollectionsTM) and generated its own Keymical SpaceTM representing over 8 M cpds. The EDEN platform (Edelris Discovery ENgine) has been developed to combine the leading role of structural information in drug discovery with the attractiveness of our Keymical SpaceTM in order to design compounds exploring new boundaries in the modulation of biological systems and particularly to address PPIs.

We will present in this webinar the approach used to design compounds mimicking alpha helix peptide secondary structures. 3D-Pharmacophore data mining using ReCore proved to be successful to discover original and drug-like modulators of the MDM2/P53 interaction.

Current news

CHEMriya Update November
November 11, 2026 11:19 CET
More Chemistry. More Possibilities. The latest update of CHEMriya brings over 794 billion virtual product molecules to your compound exploration. Developed by OTAVA in collaboration with BioSolveIT, this on-demand Chemical Space opens up new opportunities for hit expansion, hit-to-lead optimization, and compound evolution. The November 2026 release combines OTAVA’s chemistry...
Read on
category
Challenge
Winter 2026 Scientific Challenge Deadline Approaching
November 3, 2026 13:18 CET
The Winter 2026 Scientific Challenge is here! We invite researchers from academia (students, postdocs, and professors), non-profit organizations, and independent researchers to take part. Whether you are exploring a new drug discovery idea or looking to advance an existing project, our software can help you take your research further. How...
Read on
CORE by Onepot.AI – Access now with our tools
October 27, 2026 14:38 CET
Bringing Robotic Synthesis to Chemical Space Exploration A new Chemical Space is now available for your compound exploration: onepot’s CORE Space brings over 10 billion virtual product molecules to your drug discovery projects. CORE (Compounds On-demand via Robotic Execution) combines reactions widely used in medicinal chemistry with building blocks that...
Read on